Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that remains incurable, despite decades of basic and clinical research. Key stakeholders—including the US National ...
LAS VEGAS , NV, UNITED STATES, December 16, 2024 /EINPresswire / -- DelveInsight's“Amyotrophic Lateral Sclerosis Insights, Epidemiology, and market Forecast-2034” report offers an in-depth ...
In a real-world study, In the end, researchers compared 395 ALS patients who'd been given Radicava against 395 matched ...
Treatment with intravenous (IV) edaravone was associated with fewer reported disease progression milestones and deaths in patients with amyotrophic ...
The genes included those involved in the function of energy-producing mitochondria, lipid and iron metabolism, and the ...
Epub 2015 Jul 27. Henry KA, Fagliano J, Jordan HM, Rechtman L, Kaye WE. Geographic variation of amyotrophic lateral sclerosis incidence in New Jersey, 2009-2011. Am J Epidemiology 2015;doi: ...
Trouble sleeping is common in other neurodegenerative diseases, but past research has only suggested that it occurs in patients with amyotrophic lateral sclerosis. Now, a new study has not only ...
Its lead product is NeuroNata-R (lenzumestrocel), the world’s first stem cell-based therapy for amyotrophic lateral sclerosis (ALS). NeuroNata-R was approved as an orphan drug for the treatment ...
Hawking authored numerous books throughout his career and gave guest lectures around the world despite being paralyzed from amyotrophic lateral sclerosis, commonly known as ALS or Lou Gehrig’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback